Neurolink, based in San Jose, California, is a biotechnology and pharmaceutical company that has been pioneering new treatments for Central Nervous System (CNS) disorders since its establishment in 2008. The company has received a $2.26M Venture Round investment on 28 December 2010. Neurolink Medical, Inc. is dedicated to developing innovative therapies for CNS disorders and has garnered the attention of venture capitalists seeking to support advancements in this critical field.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $2.26M | - | 28 Dec 2010 | |
Venture Round | $1.62M | - | 18 Oct 2010 |